Rifamycin SV MMX

Cosmo Scraps Partnership Plans After Santarus Windfall, CEO Says
Bloomberg
Mon, 02/3/14 - 08:29 am
Santarus
Cosmo Pharma
Rifamycin SV MMX
Santarus Collaborates with Cosmo for U.S. Rights to Budesonide MMX and Rifamycin SV MMX
Trading Markets
Sat, 12/20/08 - 11:14 am
Santarus
Cosmo Pharma
Budesonide MMX
Rifamycin SV MMX